Variant NM_000492.4:c.1519_1521del
Name | NM_000492.4:c.1519_1521del |
Protein name | NP_000483.3:p.(Ile507del) |
Genomic name (hg19) | chr7:g.117199644_117199646del UCSC |
#Exon/intron | exon 11 |
Legacy Name | ΔI507 |
Class | disease-causing |
Subclass | CF-causing |
WT sequence | GCCTGGCACCATTAAAGAAAATATC ATC TTTGGTGTTTCCTATGATGAATATA |
Mutant sequence | GCCTGGCACCATTAAAGAAAATATC --- TTTGGTGTTTCCTATGATGAATATA |
dbSNP rs121908745 |
Not found |
Reference | PMID | Splicing | mRNA level | Maturation | Localization | Channel fonction (Cl-) | Bicarbonate |
Gregory et al, 1991 | 1712898 | ✓ | ✓ |
« ✓ » indicates the type of analysis performed and not the results
No patient found in CFTR-NGS catalogue |
TOTAL NUMBER OF PATIENTS | 51 |
---|---|
Asymptomatic compound heterozygote | 2 |
CF | 40 |
CFTR-RD | 8
|
Pending (NBS) | 1 |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
Phenotype | Patient ID | Variant status | Additional variants |
---|---|---|---|
CF | 3383 | heterozygote | CF-causing - Trans |
CF | 3330 | heterozygote | CF-causing - Trans |
CF | 3153 | heterozygote | CF-causing - Trans |
CF | 3056 | heterozygote | CF-causing - Trans |
CF | 2810 | heterozygote | CF-causing - Trans |
CF | 2772 | heterozygote | CF-causing - Trans |
CF | 2181 | heterozygote | varying clinical consequence- Undef |
CF | 2155 | heterozygote | CF-causing - Trans |
CF | 1986 | heterozygote | CF-causing- Undef |
CF | 3433 | heterozygote | CF-causing - Trans |
CF | 3639 | heterozygote | CF-causing - Trans |
CF | 3674 | heterozygote | CF-causing - Trans |
CF | 4485 | heterozygote | varying clinical consequence - Trans |
CF | 4399 | heterozygote | CF-causing - Trans |
CF | 4395 | heterozygote | CF-causing - Trans |
CF | 4237 | heterozygote | CF-causing - Trans |
CF | 4144 | heterozygote | CF-causing - Trans |
CF | 4069 | heterozygote | CF-causing - Trans |
CF | 4013 | heterozygote | CF-causing - Trans |
CF | 3873 | heterozygote | CF-causing - Trans |
CF | 3757 | heterozygote | CF-causing- Undef |
CF | 5449 | heterozygote | CF-causing - Trans |
CF | 5285 | heterozygote | CFTR-RD-causing - Trans CFTR-RD-causing - Trans CFTR-RD-causing - Trans |
CF | 1787 | heterozygote | CF-causing - Trans |
CF | 1016 | heterozygote | CF-causing - Trans |
CF | 816 | heterozygote | CF-causing - Trans |
CF | 636 | heterozygote | CF-causing - Trans |
CF | 381 | heterozygote | varying clinical consequence - Trans |
CF | 153 | heterozygote | CF-causing - Trans |
CF | 148 | heterozygote | CF-causing - Trans |
CF | 141 | heterozygote | CF-causing - Trans |
CF | 137 | heterozygote | CF-causing - Trans |
CF | 1107 | heterozygote | CF-causing - Trans |
CF | 1707 | heterozygote | CF-causing- Undef |
CF | 1699 | heterozygote | varying clinical consequence- Undef |
CF | 1698 | heterozygote | varying clinical consequence- Undef |
CF | 1686 | heterozygote | CF-causing - Trans |
CF | 1608 | heterozygote | CF-causing- Undef |
CF | 1152 | heterozygote | CF-causing - Trans |
CF | 4688 | heterozygote | varying clinical consequence - Trans |
CRS-NP | 95 | heterozygote | varying clinical consequence- Undef |
CBAVD | 5129 | heterozygote | CFTR-RD-causing- Undef |
CBAVD | 1780 | heterozygote | varying clinical consequence- Undef |
CBAVD | 1748 | heterozygote | varying clinical consequence- Undef |
CBAVD | 1280 | heterozygote | CFTR-RD-causing- Undef |
Asymptomatic compound heterozygote | 3020 | heterozygote | varying clinical consequence - Trans |
Asymptomatic compound heterozygote | 1083 | heterozygote | |
Other | 1134 | heterozygote | varying clinical consequence- Undef |
Bronchiectasis | 1761 | heterozygote | |
Pancreatitis | 6191 | heterozygote | CFTR-RD-causing- Undef |
Pending (NBS) | 5237 | heterozygote | CFTR-RD-causing - Trans |
Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
CFTR variants are clustered into five groups: |
|